European Union - English - EMA (European Medicines Agency)

bial - portela ca, s.a. - eslicarbazepine acetate - epilepsy - antiepileptics, - exalief is indicated as adjunctive therapy in adults with partial-onset seizures with or without secondary generalisation.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

eisai ltd - eslicarbazepine acetate - tablet - 800mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

eisai ltd - eslicarbazepine acetate - tablet - 200mg

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - eslicarbazepine acetate - tablet - eslicarbazepine acetate 800 mg - antiepileptics

Israel - English - Ministry of Health

truemed ltd, israel - eslicarbazepine acetate - tablets - eslicarbazepine acetate 200 mg - eslicarbazepine - zebinix is indicated as:• monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;• adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

Israel - English - Ministry of Health

truemed ltd, israel - eslicarbazepine acetate - tablets - eslicarbazepine acetate 800 mg - eslicarbazepine - zebinix is indicated as:• monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;• adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - eslicarbazepine acetate - tablet - 800 milligram(s) - carboxamide derivatives; eslicarbazepine

European Union - English - EMA (European Medicines Agency)

bial - portela & ca, s.a. - eslicarbazepine acetate - epilepsy - antiepileptics, - zebinix is indicated as adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.

Canada - English - Health Canada

sumitomo pharma canada, inc. - eslicarbazepine acetate - tablet - 200mg - eslicarbazepine acetate 200mg - miscellaneous anticonvulsants

Canada - English - Health Canada

sumitomo pharma canada, inc. - eslicarbazepine acetate - tablet - 400mg - eslicarbazepine acetate 400mg - miscellaneous anticonvulsants